Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Brachytherapy has become an essential pillar in all-stages of localized prostate cancer,
where dose escalation has been demonstrated to improve outcome. HDR brachytherapy …

Abstract Background and Purpose High dose-rate (HDR) brachytherapy as a monotherapy
is an accepted treatment for localized prostate cancer, but the optimal dose and fractionation …

Purpose To update outcome and toxicity results of a prospective trial of 19-Gy single-fraction
high-dose-rate (HDR) brachytherapy for men with low-and intermediate-risk prostate cancer …

Objective.-The purpose of the guidelines national committee ccAFU was to propose updated
french guidelines for prostate cancer. Methods.-A Medline search was achieved between …

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study
assessing the efficacy and safety of a single-dose SBRT for men with localized prostate …

Purpose To evaluate acute and late genitourinary toxicity, the gastrointestinal toxicity, and
the long-term biochemical control after high-dose-rate (HDR) monotherapy in one fraction …

Following adoption of moderately hypofractionated radiotherapy as a standard for localised
prostate cancer, ultrahypofractioned radiotherapy delivered in five to seven fractions is …

Background HDR brachytherapy alone is effective for the treatment of localised prostate
cancer when given in 2–4 or more fractions. Single dose treatment has been explored in …

Introduction Isolated local recurrence of prostate cancer following primary radiotherapy or
brachytherapy may be treated with focal salvage high dose rate brachytherapy, although …